Contact this trialFirst, we need to learn more about you.
ANAVEX2-73 oral liquid +1 More for Rett Syndrome
Recruiting0 awardsPhase 2 & 3
Toronto, Ontario
This trial tests a liquid medicine called ANAVEX2-73 for children aged 5-17 with Rett Syndrome. The medicine is designed to improve brain function by targeting specific pathways. The study will last several weeks, with an option to continue for several months.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.